| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
See Remarks | General Counsel And Secretary
1 company
Tahl Cindy is a See Remarks at FATE THERAPEUTICS INC. Recent SEC Form 4 filings include 0 buys and 6 sells.
Estimated insider holdings value: $1.0M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Oct 15, 2019 | FATE Fate Therapeutics Inc | General Counsel And Secretary | Sell | 10,200 | $14.24 | $145,291.86 | -11.3% | |
| Mar 1, 2019 | FATE Fate Therapeutics Inc | General Counsel And Secretary | Sale+OE | 25,000 | $16.15 | $403,697.50 | -21.7% | |
| Feb 25, 2019 | FATE Fate Therapeutics Inc | General Counsel And Secretary | Sale+OE | 25,000 | $16.07 | $401,820.00 | -21.7% | |
| Jan 7, 2019 | FATE Fate Therapeutics Inc | General Counsel And Secretary | Sale+OE | 25,000 | $16.00 | $400,000.00 | -35.5% | |
| Oct 16, 2017 | FATE Fate Therapeutics Inc | General Counsel And Secretary | Sell | 8,091 | $3.85 | $31,123.53 | -8.1% |